At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 75 enrolled
Drug / intervention
Baclofen +1 moredrug
Likely dose
Baclofen 50mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Baclofen as Add-On to Standard Treatment of Alcohol- Dependent Patients and Its Effect on Quality of Life, Clinical and Psychosocial Features: A 12-Week Double-Blind Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Baclofen and Control group for Alcohol Dependence. Completed, enrolled 75 participants across 1 site.
Detailed Summary
This is a study of Baclofen as an add-on to standard treatment for alcohol-dependent patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Dependence
CountriesIsrael
CollaboratorsMinistry of Health, Israel
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 2009
Enrollment StartJan 2010
Primary CompletionMay 2012
Study CompletionDec 2012
TodayJul 2026
First PostedOct 27, 2009
Enrollment StartJan 1, 2010
Primary CompletionMay 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 16.7 years ago
Interventions
Baclofendrug
Baclofen 50mg per day for 12 weeks and psychosocial intervention
Control groupother
psychosocial intervention and placebo for 12 weeks